An Evaluation of Niacinamide in the Treatment of Childhood Schizophrenia
GERALD H. C. GREENBAUM M.D.1
1 Clinical teacher, department of psychiatry, faculty of medicine, University of Toronto, and staff psychiatrist, department of psychiatry, the Hospital for Sick Children, 555 University Ave., Toronto 2, Canada
The author evaluated 57 schizophrenic children clinically and psychologically before and after a six-month administration of niacinamide. They were separated into three groups: those given niacinamide, those given niacinamide plus a tranquilizer, and those given a placebo. There was no significant difference attributable to niacinamide; also, tests for the "mauve factor" in the urine of 28 of the children were negative.
